Open an account

Pro-Dex

PDEX · NASDAQ

$59.40+$1.70 (+2.94%)TodayMarket closed ·
Prev close $57.70

About PDEX

Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The company is headquartered in Irvine, California and currently employs 181 full-time employees. The firm has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. The company also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. The company manufactures machined sub-assemblies and also produces parts and assemblies for aerospace and defense systems.

Employees
180
Headquarters
Irvine, California
Listed
May 31, 1994
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
pro-dex.com

PDEX key statistics

Market cap
192.04M
Price-earnings ratio
14.00
Dividend yield
—
Average volume
49.99K
Volume
23.18K
Open price
$57.66
High today
$60.21
Low today
$57.66
52 Week high
$77.00
52 Week low
$25.25

Pro-Dex (PDEX) at a glance

Pro-Dex (PDEX) last traded at $59.40, with a market cap of 192.04M and a price-to-earnings ratio of 14.00.

Today the stock has traded between $57.66 and $60.21. The current price is 3.0% above the day's low and 1.4% below its high.

Volume so far is 23.18K shares, below the average of 49.99K shares a day.

Over the past year Pro-Dex has ranged from $25.25 to $77.00, and now sits 66% of the way up that range.

Pro-Dex met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.87 per share against an estimate of $0.6834.

The average analyst price target is $75.48, 27.1% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 3 analystsAvg $75.48
Low
$74.74
Now
$59.40
High
$77.70

PDEX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 85.4% on average.

  1. Q3 FY24: reported $0.19 per share against an estimate of $0.357
  2. Q4 FY24: reported $0.46 per share against an estimate of $0.357
  3. Q1 FY25: reported $0.75 per share against an estimate of $0.2958
  4. Q2 FY25: reported $0.61 per share against an estimate of $0.3876
  5. Q3 FY25: reported $0.82 per share against an estimate of $0.4794
  6. Q4 FY25: reported $0.36 per share against an estimate of $0.4794
  7. Q1 FY26: reported $1.40 per share against an estimate of $0.51
  8. Q2 FY26: reported $0.87 per share against an estimate of $0.6834

PDEX news

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • Avi Kapoor

    PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

Similar companies

Companies in the same industry as Pro-Dex

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.